Pune: Serum Institute To Supply Corona Vaccine To 100 Countries, Agreement Signed With UNICEF  

Share this News:

Pune, February 4, 2021: The Serum Institute of India (SII) and UNICEF have entered an agreement for long-term supply of the Corona vaccine Covishield and Novavax. Under this agreement, 1.1 billion vaccine doses will be sent to 100 countries.

India is one of the largest vaccine manufacturers in the world and many countries have approached India to purchase the Corona vaccine.

Significantly, Oxford-AstraZeneca’s Corona Vaccine Covishield is being manufactured by Serum Institute in Pune, and Novavax is produced by US-based Novax Inc. UNICEF Executive Director Henrietta Four announced an agreement with Serum Institute based in Pune.

UNICEF Executive Director Henrietta Four said that we, along with several organizations, including the Pan American Health Organization (PAHO), have ordered 1.1 billion vaccine doses for 100 countries. This vaccine will be given to low-income groups for the US $ 3.

UNICEF stated, “We look forward to working with SII to distribute these vaccines to countries subject to the approval of the vaccine by the World Health Organization (WHO). The COVAX initiative has started to deliver the corona vaccine to the people of lower-income groups. It is headed by the United Nations.”

Under the COVAX initiative, the Corona vaccine will be provided at affordable rates to labourers and people of lower-income groups from 145 countries.